Washington Trust’s Editas Medicine EDIT Stock Holding History

Washington Trust’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-442	Closed	-$561	–	795
2024 Q4	$561	Hold	442	–	–	﹤0.01%	835
2024 Q3	$1.51K	Hold	442	–	–	﹤0.01%	816
2024 Q2	$2.06K	Hold	442	–	–	﹤0.01%	813
2024 Q1	$3.28K	Hold	442	–	–	﹤0.01%	780
2023 Q4	$4.48K	Hold	442	–	–	﹤0.01%	725
2023 Q3	$3.45K	Hold	442	–	–	﹤0.01%	721
2023 Q2	$3.64K	Hold	442	–	–	﹤0.01%	735
2023 Q1	$3.21K	Hold	442	–	–	﹤0.01%	769
2022 Q4	$3.92K	Hold	442	–	–	﹤0.01%	749
2022 Q3	$5K	Hold	442	–	–	﹤0.01%	712
2022 Q2	$5K	Hold	442	–	–	﹤0.01%	712
2022 Q1	$8K	Hold	442	–	–	﹤0.01%	692
2021 Q4	$12K	Hold	442	–	–	﹤0.01%	650
2021 Q3	$18K	Hold	442	–	–	﹤0.01%	701
2021 Q2	$25K	Hold	442	–	–	﹤0.01%	657
2021 Q1	$19K	Hold	442	–	–	﹤0.01%	676
2020 Q4	$31K	Hold	442	–	–	﹤0.01%	589
2020 Q3	$12K	Hold	442	–	–	﹤0.01%	701
2020 Q2	$13K	Hold	442	–	–	﹤0.01%	617
2020 Q1	$9K	Buy	+442	New	+$11.1K	﹤0.01%	683

Other funds holding EDIT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Washington Trust's EDIT Position: Q1 2025 in Review

Washington Trust sold out of Editas Medicine (EDIT) in Q1 2025, closing a stake of 442 shares — an estimated $561 sold.

Washington Trust first reported a position in EDIT in Q1 2020 and held it in 20 quarters. The position peaked at $31K in Q4 2020. 194 funds tracked by Wall St. Rank hold EDIT as of Q1 2025.

Washington Trust reported no remaining Editas Medicine position as of Q1 2025 after selling out during the quarter.
Washington Trust sold 442 Editas Medicine shares in Q1 2025, an estimated $561.
Washington Trust first reported a position in Editas Medicine in Q1 2020 and held it in 20 quarters.
Washington Trust's Editas Medicine position peaked at $31K in Q4 2020.
194 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2025.

Based on Washington Trust's 13F filing for Q1 2025, filed 25 Apr 2025.